Astellas Pharma throws lifeline to Maxygen
Posted on July 2, 2009 at 11:00 AM
Filed under: Joint Ventures and Alliances
Tagged: Astellas Pharma , Lazard & Co. , Maxygen
Filed under: Joint Ventures and Alliances
Tagged: Astellas Pharma , Lazard & Co. , Maxygen
Biotechnology firm Maxygen Inc. (NASDAQ:MAXY) has gotten a life-saving assist from Astellas Pharma Inc. of Japan. The companies are forming a joint venture that will keep Maxygen operating in a brutal market for developmental stage biotechs with no marketable products and sky-high R&D costs. As this Deal Pipeline timeline shows (subscription required),... Continue reading
























And the winners are...



